15-29124740-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015307.2(ENTREP2):c.1250C>T(p.Pro417Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,550,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015307.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENTREP2 | NM_015307.2 | c.1250C>T | p.Pro417Leu | missense_variant | 10/11 | ENST00000261275.5 | NP_056122.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENTREP2 | ENST00000261275.5 | c.1250C>T | p.Pro417Leu | missense_variant | 10/11 | 5 | NM_015307.2 | ENSP00000261275 | P1 | |
ENTREP2 | ENST00000560021.1 | n.986C>T | non_coding_transcript_exon_variant | 7/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000387 AC: 6AN: 154868Hom.: 0 AF XY: 0.0000485 AC XY: 4AN XY: 82428
GnomAD4 exome AF: 0.0000365 AC: 51AN: 1398310Hom.: 0 Cov.: 31 AF XY: 0.0000377 AC XY: 26AN XY: 689610
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.1250C>T (p.P417L) alteration is located in exon 10 (coding exon 10) of the FAM189A1 gene. This alteration results from a C to T substitution at nucleotide position 1250, causing the proline (P) at amino acid position 417 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at